AAAAAA

   
Results: 1-13 |
Results: 13

Authors: YAZICI H SAIP P INANC S ONAT H DALAY N
Citation: H. Yazici et al., INVESTIGATION OF THE MOLECULAR-CHANGES DURING CHEMOTHERAPY IN NON-HODGKINS-LYMPHOMA, Research communications in molecular pathology and pharmacology, 100(3), 1998, pp. 301-311

Authors: CAY F ONAT H SAIP P KARS A DEMIRKAZIK A AKBULUT H KOCA S AKYOL F AKTAN G FIRAT D
Citation: F. Cay et al., CISPLATIN AND EPIRUBICIN INDUCTION CHEMOTHERAPY FOLLOWED BY CHEMORADIOTHERAPY IN LIMITED STAGE SMALL-CELL LUNG-CANCER (LS-SCLC), Annals of oncology, 9, 1998, pp. 502-502

Authors: DEMIRKAZIK A ONAT H SAIP P OZGUROGLU M KARS A CAY F DEMIR G UNER A ARPACI F AKTAN G
Citation: A. Demirkazik et al., HIGH-DOSE EPIRUBICIN AND CISPLATIN INDUCTION CHEMOTHERAPY SEQUENTIALLY FOLLOWED BY IFOSFAMIDE AND ETOPOSIDE CHEMOTHERAPY IN EXTENSIVE-STAGESMALL-CELL LUNG-CANCER (ES-SCLC), Annals of oncology, 9, 1998, pp. 505-505

Authors: INANC SE ALICI S SAIP P KURUL S ONAT H
Citation: Se. Inanc et al., HIGH-DOSE IFOSPHAMIDE IN REFRACTORY, RECURRENT AND METASTATIC SARCOMA, Annals of oncology, 9, 1998, pp. 567-567

Authors: SAIP P ONAT H BASARAN M TAS F DEMIR C UYGUN K TOPUZ E
Citation: P. Saip et al., CLINICAL EFFICACY OF DIAZEPAM IN PROPHYLAXIS OF ACUTE AND DELAYED EMESIS INDUCED BY CISPLATIN-BASED CHEMOTHERAPY - A PROSPECTIVE RANDOMIZEDTRIAL, Annals of oncology, 9, 1998, pp. 701-701

Authors: SAIP P YASASEVER V TENEKECI N AYDINER A INANC S ONAT H DISCI R TOPUZ E
Citation: P. Saip et al., PREDICTION OF RADIOLOGICAL RESPONSE OF BONE METASTASES TO THERAPY BY BIOCHEMICAL MARKER MONITORING IN PATIENTS WITH BREAST-CANCER - A PRELIMINARY-STUDY, Journal of tumor marker oncology, 13(3), 1998, pp. 45-52

Authors: TOPUZ E SAIP P AYDINER A SALIHOGLU Y BERKMAN S BENGISU E
Citation: E. Topuz et al., INTRAPERITONEAL CISPLATIN-MITOXANTRONE AND INTRAVENOUS IFOSFAMIDE COMBINATION AS FIRST-LINE TREATMENT OF OVARIAN-CANCER, European journal of gynaecological oncology, 19(3), 1998, pp. 265-270

Authors: TOPUZ E SAIP P AYDINER A SALIHOGLU Y YILMAZ T TOPUZLU C
Citation: E. Topuz et al., CATHETER COMPLICATIONS ASSOCIATED WITH INTRAPERITONEAL CHEMOTHERAPY, European journal of gynaecological oncology, 19(3), 1998, pp. 275-279

Authors: SAIP P BASARAN M AYDIMER A ERDOGAN O SALEPCI T TAS F TOPUZ E
Citation: P. Saip et al., ECG AND BLOOD-PRESSURE CHANGES DURING THE 6-HOURS PACLITAXEL INFUSION, European journal of cancer, 33, 1997, pp. 247-247

Authors: BERRAK E ASLAY I OZTURK N DINCER M AYDINER A OZBILEN S DISCI R SAIP P TOPUZ E TORE G
Citation: E. Berrak et al., THE EFFECTS OF DIFFERENT TREATMENT MODELS ON TURKISH WOMEN WITH UTERINE SARCOMA, European journal of cancer, 33, 1997, pp. 943-943

Authors: TOPUZ E TAS F AYDINER A DEMIR C SAIP P SALEPCI T KARADENIZ A ERTURK N
Citation: E. Topuz et al., ORAL ETOPOSIDE IN PATIENTS WITH SMALL-CELL LUNG-CANCER, European journal of cancer, 33, 1997, pp. 1072-1072

Authors: AYDINER A TAS F SAIP P KARADENIZ A DEMIR C SALEPCI T TOPUZ E
Citation: A. Aydiner et al., ORAL ETOPOSIDE IN PATIENTS (PTS) WITH KAPOSIS-SARCOMA (KS), European journal of cancer, 33, 1997, pp. 1178-1178

Authors: TOPUZ E AYDINER A SAIP P BENGISU E BERKMAN S DISCI R
Citation: E. Topuz et al., INTRAPERITONEAL CISPLATIN - MITOXANTRONE IN OVARIAN-CANCER PATIENTS WITH MINIMAL RESIDUAL DISEASE, European journal of gynaecological oncology, 18(1), 1997, pp. 71-75
Risultati: 1-13 |